256 related articles for article (PubMed ID: 8545243)
41. Majonoside-R2, a major constituent of Vietnamese ginseng, attenuates opioid-induced antinociception.
Huong NT; Matsumoto K; Yamasaki K; Duc NM; Nham NT; Watanabe H
Pharmacol Biochem Behav; 1997; 57(1-2):285-91. PubMed ID: 9164584
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of spinal opioid antinociception by intrathecal beta-endorphin1-27 in the rat.
Hong M; Sutak M; Jhamandas K
Br J Pharmacol; 1993 Apr; 108(4):1137-42. PubMed ID: 8485623
[TBL] [Abstract][Full Text] [Related]
43. Differential effects of forskolin and phorbol-13-myristate injected intrathecally or intracerebroventricularly on antinociception induced by morphine or beta-endorphin administered intracerebroventricularly in the mouse.
Suh HW; Song DK; Sim YB; Chung KM; Kim YH
Neuropeptides; 1996 Apr; 30(2):177-85. PubMed ID: 8771560
[TBL] [Abstract][Full Text] [Related]
44. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
45. The antinociception produced by intrathecal morphine, calcium, A23187, U50,488H, [D-Ala2, N-Me-Phe4, Gly-ol]enkephalin and [D-Pen2, D-Pen5]enkephalin after intrathecal administration of calcitonin gene-related peptide in mice.
Welch SP; Singha AK; Dewey WL
J Pharmacol Exp Ther; 1989 Oct; 251(1):1-8. PubMed ID: 2552070
[TBL] [Abstract][Full Text] [Related]
46. Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and beta-endorphin in mice.
Suh HH; Tseng LF
Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):67-71. PubMed ID: 1976234
[TBL] [Abstract][Full Text] [Related]
47. Increase of nitric oxide by L-arginine potentiates beta-endorphin- but not mu-, delta- or kappa-opioid agonist-induced antinociception in the mouse.
Xu JY; Tseng LF
Eur J Pharmacol; 1993 May; 236(1):137-42. PubMed ID: 8391452
[TBL] [Abstract][Full Text] [Related]
48. Antinociceptive mechanisms of dipsacus saponin C administered intracerebroventricularly in the mouse.
Suh HW; Song DK; Son KH; Wie MB; Lee KH; Jung KY; Do JC; Kim YH
Gen Pharmacol; 1996 Oct; 27(7):1167-72. PubMed ID: 8981063
[TBL] [Abstract][Full Text] [Related]
49. Interactions of cocaine with morphine, U-50,488H and [D-Pen2, D-Pen5]enkaphalin.
Bhargava HN; Cao YJ
Peptides; 1998; 19(3):563-8. PubMed ID: 9533646
[TBL] [Abstract][Full Text] [Related]
50. Effects of intracerebroventricularly administered mu-, delta- and kappa-opioid agonists on locomotor activity of the guinea pig and the pharmacology of the locomotor response to U50,488H.
Bot G; Chahl LA; Brent PJ; Johnston PA
Neuropharmacology; 1992 Sep; 31(9):825-33. PubMed ID: 1359440
[TBL] [Abstract][Full Text] [Related]
51. Supraspinal neurotensin-induced antianalgesia in mice is mediated by spinal cholecystokinin.
Holmes BB; Rady JJ; Smith DJ; Fujimoto JM
Jpn J Pharmacol; 1999 Feb; 79(2):141-9. PubMed ID: 10202849
[TBL] [Abstract][Full Text] [Related]
52. Effects of ACEA-1328, a NMDA receptor/glycine site antagonist, on U50,488H-induced antinociception and tolerance.
Lutfy K; Doan P; Nguyen M; Weber E
Eur J Pharmacol; 1999 Nov; 384(1):1-5. PubMed ID: 10611412
[TBL] [Abstract][Full Text] [Related]
53. Effects of ginsenosides injected intrathecally or intracerebroventricularly on antinociception induced by beta -endorphin administered intracerebroventricularly in the mouse.
Suh HW; Song DK; Huh SO; Kim YH
Neuropeptides; 1999 Apr; 33(2):101-6. PubMed ID: 10657478
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord.
Machelska H; Labuz D; Przewłocki R; Przewłocka B
J Pharmacol Exp Ther; 1997 Aug; 282(2):977-84. PubMed ID: 9262366
[TBL] [Abstract][Full Text] [Related]
55. Antianalgesic action of dynorphin A mediated by spinal cholecystokinin.
Rady JJ; Holmes BB; Fujimoto JM
Proc Soc Exp Biol Med; 1999 Mar; 220(3):178-83. PubMed ID: 10193446
[TBL] [Abstract][Full Text] [Related]
56. [D-Pen2-D-Pen5]enkephalin, a delta opioid agonist, given intracerebroventricularly in the mouse produces antinociception through medication of spinal GABA receptors.
Holmes BB; Fujimoto JM
Pharmacol Biochem Behav; 1994 Nov; 49(3):675-82. PubMed ID: 7862723
[TBL] [Abstract][Full Text] [Related]
57. Partial antinociceptive cross-tolerance to intracerebroventricular beta-endorphin in mice tolerant to systemic morphine.
Tseng LF; Lin JJ; Collins KA
Eur J Pharmacol; 1993 Sep; 241(1):63-70. PubMed ID: 8223926
[TBL] [Abstract][Full Text] [Related]
58. Antisense oligodeoxynucleotide to a delta-opioid receptor given intrathecally blocks i.c.v. administered beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA
Life Sci; 1994; 55(7):PL127-31. PubMed ID: 8041224
[TBL] [Abstract][Full Text] [Related]
59. Delta opioid antagonist, naltrindole, selectively blocks analgesia induced by DPDPE but not DAGO or morphine.
Calcagnetti DJ; Holtzman SG
Pharmacol Biochem Behav; 1991 Jan; 38(1):185-90. PubMed ID: 2017444
[TBL] [Abstract][Full Text] [Related]
60. Blockade of mu-opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice.
Mizoguchi H; Hung KC; Leitermann R; Narita M; Nagase H; Suzuki T; Tseng LF
Eur J Pharmacol; 2003 Feb; 461(1):35-9. PubMed ID: 12568913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
